Exosomes targeting EGFR-mutant non-small cell lung cancer were prepared by hydrophobic interaction between fluorophore/EGFR aptamer-linked cholesterol and lipid bilayer of exosomes, following the encapsulation of STAT3 siRNA. Here, EGFR is linked to non-small cell lung carcinoma.